Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$254M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Blue Horizon Enterprise Ltd | Dec 23, 2024 | Sell | 2,000,000 | $11.5 | $23M |
| Allan Jonathan | Dec 9, 2024 | Sell | 12,114 | $13.6878 | $170,000 |
| Ticho Barry | Dec 9, 2024 | Sell | 2,586 | $12.9913 | $34,000 |
| Allan Jonathan | Dec 9, 2024 | Sell | 1,552 | $12.9923 | $20,000 |
| Kaye Edward M. MD | Dec 9, 2024 | Sell | 6,786 | $12.9912 | $88,000 |
| Ticho Barry | Dec 6, 2024 | Sell | 13,945 | $12.7775 | $180,000 |
| Allan Jonathan | Dec 6, 2024 | Sell | 9,696 | $12.7775 | $120,000 |
| Kaye Edward M. MD | Dec 6, 2024 | Sell | 6,170 | $12.7775 | $79,000 |
| Ticho Barry | Dec 2, 2024 | Sell | 10,000 | $12.0698 | $120,000 |
| Ticho Barry | Nov 1, 2024 | Sell | 10,000 | $12.6803 | $130,000 |
| Ticho Barry | Oct 1, 2024 | Sell | 10,000 | $12.0648 | $120,000 |
| Blue Horizon Enterprise Ltd | Sep 19, 2024 | Sell | 1,937,500 | $14.05 | $27M |
| Ticho Barry | Sep 3, 2024 | Sell | 9,400 | $14.9187 | $140,000 |
| Ticho Barry | Sep 3, 2024 | Sell | 600 | $15.4083 | $9,200 |
| Ticho Barry | Aug 1, 2024 | Sell | 10,000 | $14.5843 | $150,000 |
| Nash Huw M. | Jul 2, 2024 | Sell | 2,467 | $13.101 | $32,000 |
| Nash Huw M. | Jul 2, 2024 | Sell | 33 | $13.9 | $460 |
| Ticho Barry | Jul 1, 2024 | Sell | 10,000 | $13.7458 | $140,000 |
| Ticho Barry | Jun 3, 2024 | Sell | 9,897 | $15.2127 | $150,000 |
| Ticho Barry | Jun 3, 2024 | Sell | 103 | $15.78 | $1,600 |
| Nash Huw M. | May 20, 2024 | Sell | 50,000 | $15.39 | $770,000 |
| Kaye Edward M. MD | May 20, 2024 | Sell | 39,686 | $15.3904 | $610,000 |
| Kaye Edward M. MD | May 20, 2024 | Sell | 2,664 | $16.0457 | $43,000 |
| Allan Jonathan | May 20, 2024 | Sell | 8,599 | $15.0398 | $130,000 |
| Ticho Barry | May 1, 2024 | Sell | 10,000 | $11.3653 | $110,000 |
| Blue Horizon Enterprise Ltd | Apr 17, 2024 | Sell | 3,600,000 | $11.6 | $42M |
| Nash Huw M. | Apr 1, 2024 | Sell | 60,929 | $13.2247 | $810,000 |
| Ticho Barry | Apr 1, 2024 | Sell | 9,426 | $13.2277 | $120,000 |
| Nash Huw M. | Apr 1, 2024 | Sell | 400 | $13.61 | $5,400 |
| Allan Jonathan | Mar 28, 2024 | Sell | 5,026 | $13.1888 | $66,000 |
| Allan Jonathan | Mar 28, 2024 | Sell | 100 | $13.81 | $1,400 |
| Kaye Edward M. MD | Mar 19, 2024 | Sell | 11,150 | $6.0986 | $68,000 |
| Tulipano Stephen J | Mar 19, 2024 | Sell | 4,116 | $6.0986 | $25,000 |
| Ticho Barry | Mar 19, 2024 | Sell | 4,116 | $6.0986 | $25,000 |
| Nash Huw M. | Mar 19, 2024 | Sell | 4,116 | $6.0986 | $25,000 |
| Allan Jonathan | Mar 19, 2024 | Sell | 2,349 | $6.0986 | $14,000 |
| Ticho Barry | Mar 1, 2024 | Sell | 10,000 | $7.7469 | $77,000 |
| Ticho Barry | Feb 1, 2024 | Sell | 10,000 | $4.7991 | $48,000 |
| Ticho Barry | Jan 2, 2024 | Sell | 10,000 | $5.7352 | $57,000 |
| Ticho Barry | Jul 3, 2023 | Sell | 15,000 | $10.5982 | $160,000 |
| Allan Jonathan | Jun 21, 2023 | Sell | 1,948 | $13.4765 | $26,000 |
| Ticho Barry | Jun 1, 2023 | Sell | 15,000 | $11.1309 | $170,000 |
| Ticho Barry | May 4, 2023 | Sell | 653 | $10 | $6,500 |
| Ticho Barry | May 3, 2023 | Sell | 24,697 | $10.1375 | $250,000 |
| Ticho Barry | May 2, 2023 | Sell | 5,513 | $10.0007 | $55,000 |
| Ticho Barry | May 1, 2023 | Sell | 24,967 | $10.0039 | $250,000 |
| Ticho Barry | Feb 6, 2023 | Sell | 9,235 | $10.0153 | $92,000 |
| Ticho Barry | Feb 3, 2023 | Sell | 3,763 | $10.0306 | $38,000 |
| Ticho Barry | Feb 2, 2023 | Sell | 267 | $10 | $2,700 |
| Ticho Barry | Feb 1, 2023 | Sell | 5,705 | $10.0158 | $57,000 |
| Ticho Barry | Jan 31, 2023 | Sell | 200 | $10 | $2,000 |
What's the latest insider transaction for Stoke Therapeutics?
The most recent insider transaction for Stoke Therapeutics was conducted by Blue Horizon Enterprise Ltd, who sold 2,000,000 shares on December 23, 2024 at a price of $11.50 per share.
Which insider has sold the most STOK stock over the last two years?
Blue Horizon Enterprise Ltd has sold the most STOK stock in the last 2 years, with a total value of $92M.
What is the total value of insider transactions for Stoke Therapeutics (STOK) in the last 2 years?
The total value of insider transactions for Stoke Therapeutics in the last 2 years is negative, amounting to -$98M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Stoke Therapeutics' market confidence?
Over the last 2 years, insider transactions for Stoke Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
